Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models
View/ Open
Volume
51
Pagination
36 - 46
DOI
10.1016/j.exPhem.2017.04.008
Journal
EXPERIMENTAL HEMATOLOGY
ISSN
0301-472X